IS4420A - Nýir fjölgervingar af lesópítróndíklóróhýdrati oghýdreruðum myndum þess, framleiðsluaðferðir og efnablöndur sem innihalda þá - Google Patents

Nýir fjölgervingar af lesópítróndíklóróhýdrati oghýdreruðum myndum þess, framleiðsluaðferðir og efnablöndur sem innihalda þá

Info

Publication number
IS4420A
IS4420A IS4420A IS4420A IS4420A IS 4420 A IS4420 A IS 4420A IS 4420 A IS4420 A IS 4420A IS 4420 A IS4420 A IS 4420A IS 4420 A IS4420 A IS 4420A
Authority
IS
Iceland
Prior art keywords
lesopitron
dichlorohydrate
production methods
preparations containing
hydrated forms
Prior art date
Application number
IS4420A
Other languages
English (en)
Inventor
Lupon Roses Pilar
Tomas Navarro Jaime
Puig Torres Salvador
Frigola Constansa Jordi
Original Assignee
Laboratorios Del Dr. Esteve, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Del Dr. Esteve, S.A. filed Critical Laboratorios Del Dr. Esteve, S.A.
Publication of IS4420A publication Critical patent/IS4420A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS4420A 1995-05-31 1997-01-29 Nýir fjölgervingar af lesópítróndíklóróhýdrati oghýdreruðum myndum þess, framleiðsluaðferðir og efnablöndur sem innihalda þá IS4420A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES09501086A ES2099031B1 (es) 1995-05-31 1995-05-31 Nuevos polimorfos de diclorhidrato de lesopitron y sus formas hidratadas, procedimientos de preparacion y composiciones que los contienen.
PCT/ES1996/000121 WO1996038439A1 (es) 1995-05-31 1996-05-29 Nuevos polimorfos de diclorhidrato de lesopitron y sus formas hidratadas, procedimientos de preparacion y composiciones que los contienen

Publications (1)

Publication Number Publication Date
IS4420A true IS4420A (is) 1997-01-29

Family

ID=8290585

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4420A IS4420A (is) 1995-05-31 1997-01-29 Nýir fjölgervingar af lesópítróndíklóróhýdrati oghýdreruðum myndum þess, framleiðsluaðferðir og efnablöndur sem innihalda þá

Country Status (29)

Country Link
US (1) US5872125A (is)
EP (1) EP0771798A1 (is)
JP (1) JPH10503532A (is)
CN (1) CN1076020C (is)
AR (1) AR003952A1 (is)
AU (1) AU699210B2 (is)
BG (1) BG62966B1 (is)
CA (1) CA2196425A1 (is)
CO (1) CO4700461A1 (is)
CZ (1) CZ24797A3 (is)
EE (1) EE9700067A (is)
ES (1) ES2099031B1 (is)
GE (1) GEP20002241B (is)
HU (1) HUP9700284A3 (is)
IL (1) IL118494A0 (is)
IN (1) IN186820B (is)
IS (1) IS4420A (is)
MA (1) MA23883A1 (is)
MX (1) MX9700792A (is)
NO (1) NO310073B1 (is)
NZ (1) NZ308110A (is)
PL (1) PL318280A1 (is)
RU (1) RU2178789C2 (is)
SK (1) SK12697A3 (is)
TR (1) TR199600455A2 (is)
UY (1) UY24241A1 (is)
WO (1) WO1996038439A1 (is)
YU (1) YU32396A (is)
ZA (1) ZA964139B (is)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6869970B2 (en) 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2642759B1 (fr) * 1989-02-09 1991-05-17 Laboratorios Esteve Sa Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante
FR2654621B1 (fr) * 1989-11-22 1994-09-23 Esteve Labor Dr Inhibition du syndrome d'abstinence.
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
FR2671972B1 (fr) * 1991-01-25 1995-03-03 Esteve Labor Dr Utilisation de derives 1-h-azole-(omega-(4-(2-pyrimidinyl)-1-piperazinyl)-alkyl) pour la preparation de medicaments destines au traitement des troubles des fonctions cognitives.
FR2673628B1 (fr) * 1991-03-07 1993-07-09 Esteve Labor Dr Procede de preparation de derives d'aryl (ou heteroaryl)-piperazinyl-butyl-azoles.
FR2705098B1 (fr) * 1993-05-10 1995-08-04 Esteve Labor Dr Procédé de préparation de 2-{4-[4-(chloro-1-pyrazolyl)butyl]1-pipérazinyl}pyrimidine (Lesopitron) .

Also Published As

Publication number Publication date
ES2099031A1 (es) 1997-05-01
PL318280A1 (en) 1997-06-09
EE9700067A (et) 1997-10-15
UY24241A1 (es) 1996-06-14
AU699210B2 (en) 1998-11-26
RU2178789C2 (ru) 2002-01-27
ES2099031B1 (es) 1997-12-01
SK12697A3 (en) 1997-07-09
ZA964139B (en) 1997-02-06
IL118494A0 (en) 1996-09-12
MA23883A1 (fr) 1996-12-31
NO970392L (no) 1997-04-01
HUP9700284A3 (en) 1998-01-28
WO1996038439A1 (es) 1996-12-05
YU32396A (sh) 1999-07-28
GEP20002241B (en) 2000-09-25
HUP9700284A2 (en) 1997-11-28
MX9700792A (es) 1997-05-31
EP0771798A1 (en) 1997-05-07
US5872125A (en) 1999-02-16
HU9700284D0 (en) 1997-04-28
BG62966B1 (bg) 2000-12-29
CN1158128A (zh) 1997-08-27
CO4700461A1 (es) 1998-12-29
CA2196425A1 (en) 1996-12-05
CN1076020C (zh) 2001-12-12
TR199600455A2 (tr) 1996-12-21
BG101176A (en) 1997-08-29
NO970392D0 (no) 1997-01-29
JPH10503532A (ja) 1998-03-31
AU5765096A (en) 1996-12-18
IN186820B (is) 2001-11-17
AR003952A1 (es) 1998-09-30
CZ24797A3 (en) 1997-05-14
NZ308110A (en) 1997-08-22
NO310073B1 (no) 2001-05-14

Similar Documents

Publication Publication Date Title
NO973879D0 (no) Stent, og fremgangsmåte for fremstilling av samme
DE69616184D1 (de) Magnetische Kältemittelzusammensetzungen sowie Herstellungsverfahren und Benutzung
DE69635337D1 (de) Erweiterbares und austauschbares system von netzwerkkomponenten
IS5409A (is) Útskipt karboxamídóþíasól, framleiðsla þeirra og lyfjablöndur sem innihalda þau
NO961160L (no) Cykliske forbindelser, deres fremstilling og anvendelse
DE69705401D1 (de) Gesichtsmaske
IS4639A (is) Nýir þrombínhemlar, framleiðsla þeirra og notkun
NO962179D0 (no) Fremgangsmåte for fremstilling av metallocen og anvendelse derav
NO20003096D0 (no) Sammensetninger og fremgangsmÕter for behandling av ADD
IS4635A (is) 4-fenýlamínóþíasólafleiður, aðferð við að framleiða þær og lyfjablöndur sem innihalda þær
PL323723A1 (en) Novel derivatives of dolastatin, their production and application
IS1968B (is) Tilbúnar fjölsykrur, aðferð við að framleiða þær og lyfjablöndur sem innihalda þær
NO950174D0 (no) PLL syntetiserer og fremgangsmåte for styring av samme
DK1071433T3 (da) 2',2'-difluornucleosider til immunosuppressiv behandling og kombinationspræparater
DK0776363T3 (da) Ribozymbibliotek, fremstilling og anvendelse heraf
DE69621875D1 (de) Polarisationsunabhängiger Demultiplexer und Herstellungsverfahren
NO20031691D0 (no) Telekommunikasjonsnettverk og fremgangsmåte for betjening av nettverket
IT1290923B1 (it) Sacchetto e metodo per la produzione dello stesso.
IS4420A (is) Nýir fjölgervingar af lesópítróndíklóróhýdrati oghýdreruðum myndum þess, framleiðsluaðferðir og efnablöndur sem innihalda þá
IS4035A (is) Benzodiazepinesefni, aðferð til framleiðslu þeirra og notkunar sem lyfja
NO990011L (no) Vandig fortykningsmiddelsammensetning og fremgangsmÕte for fremstilling av den samme
NO20003529D0 (no) Behandling av dyskinesi
NO971419L (no) Fremgangsmåte for fremstilling av 1,3-alkendioler og 3-hydroksyaldehyder
DE69502429D1 (de) Auflösung von Gas
NO970472D0 (no) Preganer og cholaner som neurokjemiske intiatorer av forandring i hypotalamusfunksjon